6-DeoxyjacareubinCAS# 16265-56-8 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
| Cas No. | 16265-56-8 | SDF | Download SDF |
| PubChem ID | 5281629 | Appearance | Yellow powder |
| Formula | C18H14O5 | M.Wt | 310.3 |
| Type of Compound | Xanthones | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| Chemical Name | 5,10-dihydroxy-2,2-dimethylpyrano[3,2-b]xanthen-6-one | ||
| SMILES | CC1(C=CC2=C(O1)C=C3C(=C2O)C(=O)C4=C(O3)C(=CC=C4)O)C | ||
| Standard InChIKey | NHNIESSJWQBRJW-UHFFFAOYSA-N | ||
| Standard InChI | InChI=1S/C18H14O5/c1-18(2)7-6-9-12(23-18)8-13-14(15(9)20)16(21)10-4-3-5-11(19)17(10)22-13/h3-8,19-20H,1-2H3 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
| Description | 1. 6-Deoxyjacareubin, 1,5-dihydroxyxanthone, and 5-hydroxy-1-methoxyxanthoneis are antifungal against Cladosporium cucumerinum, while they show differing degrees of inhibition of monoamine oxidase A and B. 2. 6-Deoxyjacareubin shows strong platelet activating factor (PAF) receptor binding inhibitory effects using rabbit platelets with IC50 values of 29.0 microM, suggests that xanthones can represent a new class of natural PAF receptor antagonists. 3. 6-Deoxyjacareubin possesses significant antioxidant activities. 4. 6-Deoxyjacareubin exhibits the cytotoxic activities against HL-60, SMMC-7721, A-549, MCF-7, and SW-480 cell lines. |
| Targets | PAFR | Antifection |
6-Deoxyjacareubin Dilution Calculator
6-Deoxyjacareubin Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 3.2227 mL | 16.1134 mL | 32.2269 mL | 64.4538 mL | 80.5672 mL |
| 5 mM | 0.6445 mL | 3.2227 mL | 6.4454 mL | 12.8908 mL | 16.1134 mL |
| 10 mM | 0.3223 mL | 1.6113 mL | 3.2227 mL | 6.4454 mL | 8.0567 mL |
| 50 mM | 0.0645 mL | 0.3223 mL | 0.6445 mL | 1.2891 mL | 1.6113 mL |
| 100 mM | 0.0322 mL | 0.1611 mL | 0.3223 mL | 0.6445 mL | 0.8057 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- HQL 79
Catalog No.:BCC7703
CAS No.:162641-16-9
- AT 56
Catalog No.:BCC6036
CAS No.:162640-98-4
- AZD3759
Catalog No.:BCC6475
CAS No.:1626387-80-1
- Temsirolimus
Catalog No.:BCC3678
CAS No.:162635-04-3
- Sorokinianin
Catalog No.:BCN6978
CAS No.:162616-73-1
- Eriosemation
Catalog No.:BCN3738
CAS No.:162616-72-0
- Isolupalbigenin
Catalog No.:BCN6835
CAS No.:162616-70-8
- 3-Hydroxy-5,7-dimethoxy-3',4'-methylenedioxyflavan
Catalog No.:BCN1540
CAS No.:162602-04-2
- Broussoflavonol F
Catalog No.:BCN3571
CAS No.:162558-94-3
- Fmoc-Dap(Boc)-OH
Catalog No.:BCC3188
CAS No.:162558-25-0
- CDP 840 hydrochloride
Catalog No.:BCC7814
CAS No.:162542-90-7
- Salirasib
Catalog No.:BCC1918
CAS No.:162520-00-5
- Kaempferol tetraacetate
Catalog No.:BCN1721
CAS No.:16274-11-6
- 3,4-Dihydro-2,2-dimethyl-2H-naphtho[1,2-b]pyran
Catalog No.:BCN1539
CAS No.:16274-33-2
- 1-Hydroxy-2-prenylnaphthalene
Catalog No.:BCN1722
CAS No.:16274-34-3
- AZD8186
Catalog No.:BCC6470
CAS No.:1627494-13-6
- LDN-214117
Catalog No.:BCC5528
CAS No.:1627503-67-6
- Anemarrhena B
Catalog No.:BCN7592
CAS No.:1627521-95-2
- WAY-100635
Catalog No.:BCC2053
CAS No.:162760-96-5
- Yunnancoronarin A
Catalog No.:BCN1723
CAS No.:162762-93-8
- PFI-2
Catalog No.:BCC5561
CAS No.:1627676-59-8
- LJI308
Catalog No.:BCC6538
CAS No.:1627709-94-7
- 7-Epi-10-oxo-docetaxel
Catalog No.:BCC5410
CAS No.:162784-72-7
- IEM 1754 dihydrobroMide
Catalog No.:BCC5049
CAS No.:162831-31-4
Antioxidant phenolic compounds of cassava (Manihot esculenta) from Hainan.[Pubmed:22157579]
Molecules. 2011 Dec 7;16(12):10157-67.
An activity-directed fractionation and purification process was used to isolate antioxidant components from cassava stems produced in Hainan. The ethyl acetate and n-butanol fractions showed greater DPPH and ABTS.+ scavenging activities than other fractions. The ethyl acetate fraction was subjected to column chromatography, to yield ten phenolic compounds: Coniferaldehyde (1), isovanillin (2), 6-Deoxyjacareubin (3), scopoletin (4), syringaldehyde (5), pinoresinol (6), p-coumaric acid (7), ficusol (8), balanophonin (9) and ethamivan (10), which possess significant antioxidant activities. The relative order of DPPH. scavenging capacity for these compounds was ascorbic acid (reference) > 6 > 1 > 8 > 10 > 9 > 3 > 4 > 7 > 5 > 2, and that of ABTS.+ scavenging capacity was 5 > 7 > 1 > 10 > 4 > 6 > 8 > 2 > Trolox (reference compound) > 3 > 9. The results showed that these phenolic compounds contributed to the antioxidant activity of cassava.
Inhibitory effects of xanthones on platelet activating factor receptor binding in vitro.[Pubmed:11297865]
J Ethnopharmacol. 2001 May;75(2-3):287-90.
Nine naturally occurring xanthones were investigated for their platelet activating factor (PAF) receptor binding inhibitory effects using rabbit platelets. 2-(3-methylbut-2-enyl)-1,3,5-trihydoxyxanthone, macluraxanthone, 1,3,5-trihydroxy-6,6'-dimethylpyrano(2',3':6,7)-4-(1,1-dimethylprop-2-enyl)xantho ne, 6-Deoxyjacareubin and 2-(3-methylbut-2-enyl)-1,3,5,6-terahydroxyxanthone showed strong inhibition with IC50 values of 4.8, 11.0, 21.0, 29.0 and 44.0 microM, respectively. The prenyl group at C-2, the dimethylprop-2-enyl group at C-4 and the hydroxyl group at C-5 are all beneficial to the binding of xanthones to the PAF receptor. The results revealed that xanthones can represent a new class of natural PAF receptor antagonists.
An antifungal gamma-pyrone and xanthones with monoamine oxidase inhibitory activity from Hypericum brasiliense.[Pubmed:7765428]
Phytochemistry. 1994 Aug;36(6):1381-5.
A new gamma-pyrone (hyperbrasilone), three known xanthones (1,5-dihydroxyxanthone, 5-hydroxy-1-methoxyxanthone and 6-Deoxyjacareubin) and betulinic acid have been isolated from a dichloromethane extract of stems and roots of Hypericum brasiliense. Their structures were established by spectroscopic methods (UV, EI-MS, 1H and 13C NMR) and that of the gamma-pyrone was confirmed by X-ray crystallography. Hyperbrasilone and the xanthones were all antifungal against Cladosporium cucumerinum, while the three xanthones showed differing degrees of inhibition of monoamine oxidase A and B.
